# Cardiac Sarcoidosis Response To Steroids Trial

> **NCT01210677** · PHASE4 · WITHDRAWN · sponsor: **Ottawa Heart Institute Research Corporation**

## Conditions studied

- Cardiac Sarcoidosis
- Sarcoidosis

## Interventions

- **DRUG:** Prednisone

## Key facts

- **NCT ID:** NCT01210677
- **Lead sponsor:** Ottawa Heart Institute Research Corporation
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-04
- **Primary completion:** 2016-04
- **Final completion:** 2016-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No funding obtained.
- **Last updated:** 2013-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01210677

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01210677, "Cardiac Sarcoidosis Response To Steroids Trial". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01210677. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*